Taipei Exchange - Delayed Quote TWD

Orient Pharma Co., Ltd. (4166.TWO)

32.65
-0.35
(-1.06%)
As of 12:18:20 PM GMT+8. Market Open.
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,222,816
1,222,816
889,912
511,859
463,342
Cost of Revenue
571,257
571,257
421,245
356,510
320,669
Gross Profit
651,559
651,559
468,667
155,349
142,673
Operating Expense
477,649
477,649
440,914
197,085
276,161
Operating Income
173,910
173,910
27,753
-41,736
-133,488
Net Non Operating Interest Income Expense
-10,346
-10,346
-12,225
-6,285
-5,183
Pretax Income
163,123
163,123
22,924
-41,107
-110,092
Tax Provision
55,749
55,749
636
-12,348
-7,440
Net Income Common Stockholders
107,374
107,374
22,288
-28,759
-102,652
Diluted NI Available to Com Stockholders
107,374
107,374
22,288
-28,759
-102,652
Basic EPS
0.48
--
0.10
-0.15
-0.55
Diluted EPS
0.48
--
0.10
-0.15
-0.55
Basic Average Shares
223,695.83
--
222,880
187,003
187,009
Diluted Average Shares
223,035
223,695.83
222,880
187,003
187,009
Total Expenses
1,048,906
1,048,906
862,159
553,595
596,830
Net Income from Continuing & Discontinued Operation
107,374
107,374
22,288
-28,759
-102,652
Normalized Income
117,903.20
117,903.20
25,627.70
-28,759
-102,652
Interest Income
3,622
3,622
1,675
1,089
518
Interest Expense
13,968
13,968
13,900
7,374
5,701
Net Interest Income
-10,346
-10,346
-12,225
-6,285
-5,183
EBIT
177,091
177,091
36,824
-33,733
-104,391
EBITDA
312,812
312,812
172,395
35,367
-39,212
Reconciled Cost of Revenue
571,257
571,257
421,245
356,510
320,669
Reconciled Depreciation
135,721
135,721
135,571
69,100
65,179
Net Income from Continuing Operation Net Minority Interest
107,374
107,374
22,288
-28,759
-102,652
Total Unusual Items Excluding Goodwill
-15,996
-15,996
-3,435
0
--
Total Unusual Items
-15,996
-15,996
-3,435
0
--
Normalized EBITDA
328,808
328,808
175,830
35,367
-39,212
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-5,466.80
-5,466.80
-95.30
0
0
12/31/2021 - 6/20/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

4120.TWO Orient EuroPharma Co., Ltd.
47.50
0.00%
 
6677.TWO Anxo Pharmaceutical Co., Ltd.
16.30
+0.31%
 
4172.TWO InnoPharmax Inc.
17.55
-2.23%
 
6539.TWO DV Biomed Co., Ltd.
82.70
+4.42%
 
6467.TWO TAHO Pharma
59.10
+3.50%
 
1780.TWO Allied Biotech Corporation
17.85
-1.11%
 
4117.TWO General Biologicals Corporation
15.40
-0.32%
 
6483.TWO Original BioMedicals Co., Ltd.
12.00
0.00%
 
6621.TWO UniPharma Co., Ltd.
14.35
-1.71%
 
6817.TWO Winston Medical Supply Co., Ltd.
102.00
-0.97%